Literature DB >> 30010106

Annexin A5 overexpression might suppress proliferation and metastasis of human uterine cervical carcinoma cells.

Xin Li, Wenyi Ma, Xiaojie Wang, Yunzhe Ci, Yina Zhao.   

Abstract

BACKGROUND: Annexin A5 (ANXA5) is a kind of Ca2+-dependent phospholipid binding protein which is involved in cell membrane dynamics and organization. Recent data showed that ANXA5 might involve in tumorigenesis.
OBJECTIVE: To explore what role ANXA5 play in human uterine cervical carcinoma.
MATERIALS AND METHODS: In this study, a recombined ANXA5 plasmid was constructed and uterine cervical carcinoma cell lines HeLa and SiHa were transfected with it. After ANXA5 overexpression was determined by Western Blot, cell proliferation test was detected by MTT assay and colony formation assay respectively. FACS assay and Hochest33258 staining methods were employed to detect cell apoptosis. To further investigate whether ANXA5 influence cell migration and invasion, wound healing assay and transwell assay were applied. At the same time, the relative mechanism was investigated.
RESULTS: When ANXA5 expression increased, cell proliferation was inhibited by regulating the expression of bcl-2 and bax while cell metastasis was suppressed by regulating E-cadherin and MMP-9 expression.
CONCLUSION: ANXA5 overexpression in the uterine cervical carcinoma might play important roles in cell proliferation and metastasis of uterine cervical cancer cells and act as an anti-cancer gene in uterine cervical cancer.

Entities:  

Keywords:  ANXA5; apoptosis; invasion; migration; proliferation; uterine cervical carcinoma cell

Mesh:

Substances:

Year:  2018        PMID: 30010106     DOI: 10.3233/CBM-171040

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  5 in total

1.  Annexin A5 suppression promotes the progression of cervical cancer.

Authors:  Xiaojie Wang; Yarui Dai; Jialu Zhang; Xin Li
Journal:  Arch Gynecol Obstet       Date:  2022-07-07       Impact factor: 2.344

2.  AnnexinA5 Might Suppress the Phenotype of Human Gastric Cancer Cells via ERK Pathway.

Authors:  Xiaojie Wang; Yarui Dai; Yina Zhao; Meichuan Li; Jialu Zhang; Yunzhe Ci; Huan Wang; Xin Li
Journal:  Front Oncol       Date:  2021-05-12       Impact factor: 6.244

3.  Metformin Counteracts HCC Progression and Metastasis Enhancing KLF6/p21 Expression and Downregulating the IGF Axis.

Authors:  Fernanda Vacante; Pamela Senesi; Anna Montesano; Stefano Paini; Livio Luzi; Ileana Terruzzi
Journal:  Int J Endocrinol       Date:  2019-01-10       Impact factor: 3.257

4.  Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine.

Authors:  Hua Zhong; Shuai Liu; Fang Cao; Yi Zhao; Jianguo Zhou; Feng Tang; Zhaohua Peng; Yangsheng Li; Shen Xu; Chunlin Wang; Guohua Yang; Zhi-Qiang Li
Journal:  Front Immunol       Date:  2021-08-27       Impact factor: 7.561

Review 5.  Pathobiological functions and clinical implications of annexin dysregulation in human cancers.

Authors:  Llara Prieto-Fernández; Sofía T Menéndez; María Otero-Rosales; Irene Montoro-Jiménez; Francisco Hermida-Prado; Juana M García-Pedrero; Saúl Álvarez-Teijeiro
Journal:  Front Cell Dev Biol       Date:  2022-09-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.